4
Changes in Ownership
Viridian Therapeutics, Inc.DE Filed Acc 0001193125-26-092040
Chief Operating Officer gave up 3,138 shares (to pay taxes)
- Chief Operating Officer acquired 9,409 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Beetham Thomas W. · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 1 in the form | +9,409 | 16,409 | D | ||
| 2026-03-03 | Shares withheld for taxes : show line 2 in the form | −3,138 | $29.32 | $92,006 | 13,271 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-02 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +176,550 | 176,550 | D |
| 2026-03-02 | Grant or award : show line 4 in the form Restricted Stock Units | +35,300 | 35,300 | D |
| 2026-03-03 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −9,409 | 28,227 | D |
Loading xslF345X05/ownership.xml…